We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Staining Method for Electron Microscope Specimens Safer and Cost-Effective

By LabMedica International staff writers
Posted on 06 Jun 2022
Print article
Image: New staining method for electron microscope specimens is safe, cost-effective, and easy-to-use (Photo courtesy of Unsplash)
Image: New staining method for electron microscope specimens is safe, cost-effective, and easy-to-use (Photo courtesy of Unsplash)

The electron microscopic staining technique for biological specimens using uranyl acetate (UA) was first reported in 1958 and has been used in electron microscopy facilities worldwide because of its simplicity and optimal staining results. In recent years, however, international regulations on the use, acquisition, storage, and disposal of uranium compounds have become increasingly strict because uranium is used as a nuclear material for weapons. Against this backdrop, alternative staining methods have long been long awaited in the field of biological research, and several have been proposed, but none has been an effective alternative. In this context, alternative staining methods have long been expected in the bio-medical electron microscopic research field, and several have been proposed, though none has been an effective alternative. Now, researchers have developed a new staining method for electron microscope specimens based on double staining with hematoxylin, which is widely used as a staining agent for light microscopy, and lead solution. The new method is expected to replace the conventional method of double staining with uranium acetate and lead solution and is a better choice in terms of safety, cost, and ease of handling.

To develop a safe and easy-to-handle alternative staining method to UA for ultrathin sectioning in electron microscopy, researchers at Tokyo University of Technology (Tokyo, Japan) examined various commercially available dyes for light microscopy. The researchers found that double staining with Mayer's hematoxylin (MH), which is commonly used as a staining agent in light microscopy, and lead solution (Pb), exhibited staining properties equivalent to those of conventional electron microscopic double staining with UA and Pb in various tissues and cells.

Other cell organelles, such as nuclear chromatin, plasma membrane structures, ribosomes, glycogen, lipid droplets, cell adhesion apparatus, and cytoskeletal system(s), were stained with high contrast using the MH staining method. Plasma membrane staining in all samples was also satisfactory. Backscattered electron images of 200 nm semi-thin sections of mouse kidney observed by a field emission scanning electron microscope also showed that the MH and Pb staining techniques provided a wide-area and high-quality image of the renal cortical tubules and the renal glomerulus.

MH is a dye solution widely used for staining paraffin sections of diagnostic clinical specimens, and has the advantages of low cost, stable supply as a commercial product, and high safety of waste solution. On the other hand, the International Atomic Energy Agency's "International Basic Safety Standards for Protection against Ionizing Radiation and for the Safety of Radiation Sources" (BSS) has established specific exemption levels, and new regulations for radioactive materials are being developed internationally through legislation. Based on the results of this study, double staining with MH and Pb is expected to become a useful alternative to the staining method using radioactive UA in terms of reagent purchase, handling, use, storage, and liquid waste treatment.

Related Links:
Tokyo University of Technology 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.